These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35203300)

  • 41. The role of exosomes in the promotion of epithelial-to-mesenchymal transition and metastasis.
    Visan KS; Lobb RJ; Moller A
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1022-1057. PubMed ID: 32114423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
    Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
    Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
    Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
    Chen Y; Wang DD; Wu YP; Su D; Zhou TY; Gai RH; Fu YY; Zheng L; He QJ; Zhu H; Yang B
    Br J Cancer; 2017 Oct; 117(8):1192-1201. PubMed ID: 28817834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer.
    Mrozik KM; Blaschuk OW; Cheong CM; Zannettino ACW; Vandyke K
    BMC Cancer; 2018 Oct; 18(1):939. PubMed ID: 30285678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion Behaviors of Integrins in Single Cells Altered by Epithelial to Mesenchymal Transition.
    Yuan JW; Zhang YN; Liu YR; Li W; Dou SX; Wei Y; Wang PY; Li H
    Small; 2022 Feb; 18(5):e2106498. PubMed ID: 34921576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
    Rokavec M; Bouznad N; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
    Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
    Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epithelial-to-mesenchymal transition as a learning paradigm of cell biology.
    Carvalho Leão MH; Costa ML; Mermelstein C
    Cell Biol Int; 2023 Feb; 47(2):352-366. PubMed ID: 36411367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial-to-mesenchymal transition in tumor progression.
    Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
    Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Signalling mechanism(s) of epithelial-mesenchymal transition and cancer stem cells in tumour therapeutic resistance.
    Cai Z; Cao Y; Luo Y; Hu H; Ling H
    Clin Chim Acta; 2018 Aug; 483():156-163. PubMed ID: 29709449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes.
    Krohn A; Ahrens T; Yalcin A; Plönes T; Wehrle J; Taromi S; Wollner S; Follo M; Brabletz T; Mani SA; Claus R; Hackanson B; Burger M
    PLoS One; 2014; 9(6):e100249. PubMed ID: 24959847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
    Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
    Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target.
    Jonckheere S; Adams J; De Groote D; Campbell K; Berx G; Goossens S
    Cells Tissues Organs; 2022; 211(2):157-182. PubMed ID: 33401271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.